Annual EBIT
-$36.61 M
-$4.57 M-14.28%
31 December 2023
Summary:
Lumos Pharma annual earnings before interest & taxes is currently -$36.61 million, with the most recent change of -$4.57 million (-14.28%) on 31 December 2023. During the last 3 years, it has fallen by -$5.27 million (-16.80%).LUMO EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$7.64 M
+$183.00 K+2.34%
30 September 2024
Summary:
Lumos Pharma quarterly earnings before interest & taxes is currently -$7.64 million, with the most recent change of +$183.00 thousand (+2.34%) on 30 September 2024. Over the past year, it has increased by +$2.36 million (+23.63%).LUMO Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$36.33 M
+$1.29 M+3.43%
30 September 2024
Summary:
Lumos Pharma TTM earnings before interest & taxes is currently -$36.33 million, with the most recent change of +$1.29 million (+3.43%) on 30 September 2024. Over the past year, it has increased by +$285.00 thousand (+0.78%).LUMO TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LUMO EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +23.6% | +0.8% |
| 3 y3 years | -16.8% | -15.8% | -15.9% |
| 5 y5 years | -273.0% | -208.9% | -270.1% |
LUMO EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -130.8% | -105.1% | -126.0% |
Lumos Pharma EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$7.64 M(-2.3%) | -$36.33 M(-3.4%) |
| June 2024 | - | -$7.82 M(-28.0%) | -$37.62 M(-4.6%) |
| Mar 2024 | - | -$10.86 M(+8.6%) | -$39.44 M(+7.7%) |
| Dec 2023 | -$36.61 M(+14.3%) | -$10.00 M(+12.0%) | -$36.61 M(+3.3%) |
| Sept 2023 | - | -$8.93 M(-7.4%) | -$35.45 M(+4.1%) |
| June 2023 | - | -$9.64 M(+20.0%) | -$34.06 M(-15.0%) |
| Mar 2023 | - | -$8.04 M(-9.1%) | -$40.08 M(+0.8%) |
| Dec 2022 | -$32.04 M(+2.2%) | -$8.84 M(+17.0%) | -$39.77 M(+6.0%) |
| Sept 2022 | - | -$7.55 M(-51.8%) | -$37.53 M(+0.2%) |
| June 2022 | - | -$15.65 M(+102.5%) | -$37.47 M(+22.9%) |
| Mar 2022 | - | -$7.73 M(+17.2%) | -$30.48 M(-2.8%) |
| Dec 2021 | -$31.35 M(+19.2%) | -$6.59 M(-11.9%) | -$31.35 M(-18.7%) |
| Sept 2021 | - | -$7.49 M(-13.6%) | -$38.53 M(+21.5%) |
| June 2021 | - | -$8.67 M(+0.9%) | -$31.71 M(+6.3%) |
| Mar 2021 | - | -$8.59 M(-37.6%) | -$29.82 M(+13.4%) |
| Dec 2020 | -$26.30 M(+168.0%) | -$13.78 M(+1966.3%) | -$26.30 M(+75.4%) |
| Sept 2020 | - | -$667.00 K(-90.2%) | -$14.99 M(-11.8%) |
| June 2020 | - | -$6.78 M(+33.6%) | -$17.00 M(+32.9%) |
| Mar 2020 | - | -$5.08 M(+105.2%) | -$12.79 M(+30.3%) |
| Dec 2019 | -$9.82 M(-83.8%) | -$2.47 M(-7.3%) | -$9.82 M(-45.1%) |
| Sept 2019 | - | -$2.67 M(+3.9%) | -$17.89 M(-39.6%) |
| June 2019 | - | -$2.57 M(+22.0%) | -$29.61 M(-33.2%) |
| Mar 2019 | - | -$2.10 M(-80.0%) | -$44.32 M(-26.8%) |
| Dec 2018 | -$60.51 M(-16.4%) | -$10.54 M(-26.7%) | -$60.51 M(-5.1%) |
| Sept 2018 | - | -$14.39 M(-16.7%) | -$63.78 M(-9.1%) |
| June 2018 | - | -$17.28 M(-5.6%) | -$70.13 M(+0.8%) |
| Mar 2018 | - | -$18.30 M(+32.5%) | -$69.57 M(-3.9%) |
| Dec 2017 | -$72.39 M | -$13.81 M(-33.4%) | -$72.39 M(-0.0%) |
| Sept 2017 | - | -$20.74 M(+24.1%) | -$72.42 M(+5.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2017 | - | -$16.72 M(-20.8%) | -$68.52 M(-20.6%) |
| Mar 2017 | - | -$21.12 M(+52.6%) | -$86.26 M(-4.7%) |
| Dec 2016 | -$90.49 M(+169.8%) | -$13.84 M(-17.8%) | -$90.49 M(-1.1%) |
| Sept 2016 | - | -$16.84 M(-51.1%) | -$91.48 M(+1.3%) |
| June 2016 | - | -$34.46 M(+36.0%) | -$90.30 M(+25.8%) |
| Mar 2016 | - | -$25.35 M(+70.9%) | -$71.75 M(+113.9%) |
| Dec 2015 | -$33.54 M(-128.5%) | -$14.83 M(-5.3%) | -$33.54 M(-125.7%) |
| Sept 2015 | - | -$15.66 M(-1.6%) | $130.34 M(-2.0%) |
| June 2015 | - | -$15.92 M(-223.7%) | $132.99 M(-4.8%) |
| Mar 2015 | - | $12.87 M(-91.4%) | $139.75 M(+18.8%) |
| Dec 2014 | $117.66 M(-479.3%) | $149.05 M(-1246.0%) | $117.66 M(-399.4%) |
| Sept 2014 | - | -$13.01 M(+42.1%) | -$39.30 M(+14.2%) |
| June 2014 | - | -$9.15 M(-0.8%) | -$34.41 M(+6.5%) |
| Mar 2014 | - | -$9.23 M(+16.7%) | -$32.32 M(+4.2%) |
| Dec 2013 | -$31.02 M(+33.2%) | -$7.91 M(-2.5%) | -$31.02 M(+5.4%) |
| Sept 2013 | - | -$8.12 M(+14.8%) | -$29.41 M(+8.4%) |
| June 2013 | - | -$7.07 M(-10.8%) | -$27.14 M(+2.9%) |
| Mar 2013 | - | -$7.93 M(+25.7%) | -$26.38 M(+13.3%) |
| Dec 2012 | -$23.28 M(+29.0%) | -$6.31 M(+7.9%) | -$23.28 M(+2.2%) |
| Sept 2012 | - | -$5.84 M(-7.2%) | -$22.77 M(+9.0%) |
| June 2012 | - | -$6.30 M(+30.3%) | -$20.90 M(+10.0%) |
| Mar 2012 | - | -$4.83 M(-16.6%) | -$18.99 M(+5.2%) |
| Dec 2011 | -$18.05 M(+9.3%) | -$5.80 M(+46.1%) | -$18.05 M(+9.4%) |
| Sept 2011 | - | -$3.97 M(-9.6%) | -$16.49 M(-6.1%) |
| June 2011 | - | -$4.39 M(+12.9%) | -$17.57 M(+33.3%) |
| Mar 2011 | - | -$3.89 M(-8.4%) | -$13.18 M(+41.8%) |
| Dec 2010 | -$16.52 M(+59.6%) | -$4.25 M(-15.9%) | -$9.29 M(+21.2%) |
| Sept 2010 | - | -$5.05 M(+92.6%) | -$7.67 M(+192.6%) |
| Dec 2009 | -$10.35 M(+9.9%) | -$2.62 M | -$2.62 M |
| Dec 2008 | -$9.41 M | - | - |
FAQ
- What is Lumos Pharma annual earnings before interest & taxes?
- What is the all time high annual EBIT for Lumos Pharma?
- What is Lumos Pharma quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Lumos Pharma?
- What is Lumos Pharma quarterly EBIT year-on-year change?
- What is Lumos Pharma TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Lumos Pharma?
- What is Lumos Pharma TTM EBIT year-on-year change?
What is Lumos Pharma annual earnings before interest & taxes?
The current annual EBIT of LUMO is -$36.61 M
What is the all time high annual EBIT for Lumos Pharma?
Lumos Pharma all-time high annual earnings before interest & taxes is $118.76 M
What is Lumos Pharma quarterly earnings before interest & taxes?
The current quarterly EBIT of LUMO is -$7.64 M
What is the all time high quarterly EBIT for Lumos Pharma?
Lumos Pharma all-time high quarterly earnings before interest & taxes is $149.05 M
What is Lumos Pharma quarterly EBIT year-on-year change?
Over the past year, LUMO quarterly earnings before interest & taxes has changed by +$2.36 M (+23.63%)
What is Lumos Pharma TTM earnings before interest & taxes?
The current TTM EBIT of LUMO is -$36.33 M
What is the all time high TTM EBIT for Lumos Pharma?
Lumos Pharma all-time high TTM earnings before interest & taxes is $139.75 M
What is Lumos Pharma TTM EBIT year-on-year change?
Over the past year, LUMO TTM earnings before interest & taxes has changed by +$285.00 K (+0.78%)